These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 23324379)

  • 1. The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway.
    Katagiri T; Tsukamoto S
    Biol Chem; 2013 Jun; 394(6):703-14. PubMed ID: 23324379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
    J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BMP signaling and bone formation].
    Katagiri T
    Clin Calcium; 2012 Nov; 22(11):1677-83. PubMed ID: 23103811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.
    de la Peña LS; Billings PC; Fiori JL; Ahn J; Kaplan FS; Shore EM
    J Bone Miner Res; 2005 Jul; 20(7):1168-76. PubMed ID: 15940369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva.
    Katagiri T; Tsukamoto S; Kuratani M
    Bone; 2018 Apr; 109():241-250. PubMed ID: 28754575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H.
    Ohte S; Shin M; Sasanuma H; Yoneyama K; Akita M; Ikebuchi K; Jimi E; Maruki Y; Matsuoka M; Namba A; Tomoda H; Okazaki Y; Ohtake A; Oda H; Owan I; Yoda T; Furuya H; Kamizono J; Kitoh H; Nakashima Y; Susami T; Haga N; Komori T; Katagiri T
    Biochem Biophys Res Commun; 2011 Apr; 407(1):213-8. PubMed ID: 21377447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of Smads and related transcription factors in the signal transduction of bone morphogenetic protein inducing bone formation].
    Xu XL; Dai KR; Tang TT
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Sep; 17(5):359-62. PubMed ID: 14551929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into BMP receptors: Specificity, activation and inhibition.
    Yadin D; Knaus P; Mueller TD
    Cytokine Growth Factor Rev; 2016 Feb; 27():13-34. PubMed ID: 26690041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
    van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
    J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein receptor signal transduction in human disease.
    Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
    J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Billings PC; Fiori JL; Bentwood JL; O'Connell MP; Jiao X; Nussbaum B; Caron RJ; Shore EM; Kaplan FS
    J Bone Miner Res; 2008 Mar; 23(3):305-13. PubMed ID: 17967130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
    Glister C; Kemp CF; Knight PG
    Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP signaling in vascular diseases.
    Cai J; Pardali E; Sánchez-Duffhues G; ten Dijke P
    FEBS Lett; 2012 Jul; 586(14):1993-2002. PubMed ID: 22710160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation.
    Rosendahl A; Pardali E; Speletas M; Ten Dijke P; Heldin CH; Sideras P
    Am J Respir Cell Mol Biol; 2002 Aug; 27(2):160-9. PubMed ID: 12151307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP signaling in skeletal development.
    Wan M; Cao X
    Biochem Biophys Res Commun; 2005 Mar; 328(3):651-7. PubMed ID: 15694398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
    Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
    Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
    Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
    Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a novel model of chondrogenesis using murine embryonic stem cells carrying fibrodysplasia ossificans progressiva-associated mutant ALK2.
    Fujimoto M; Ohte S; Shin M; Yoneyama K; Osawa K; Miyamoto A; Tsukamoto S; Mizuta T; Kokabu S; Machiya A; Okuda A; Suda N; Katagiri T
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):347-52. PubMed ID: 25446088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.
    Ahn J; Serrano de la Pena L; Shore EM; Kaplan FS
    J Bone Joint Surg Am; 2003 Apr; 85(4):667-74. PubMed ID: 12672843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.